ClinicalTrials.gg
Not yet recruitingNCT07926061Updated Nov 9, 2026

Clinical Audit of Labour Progress and Assisted Vaginal Birth

An observational study in Labor (Obstetrics)--Complications, sponsored by Assiut University. Not yet recruiting. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Assiut University · Observational

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
150
Ages
18 Years and older
Sex
Female
01

Study summary

This observational clinical audit aims to evaluate the recording and management of labour progress and the use of assisted vaginal birth in women admitted with the intention of vaginal delivery.

Read the detailed description

The progress of labour is monitored using partograph or WHO Labour Care Guide standards. Assisted vaginal birth is recommended in eligible women with delay in the second stage, yet rates have declined in many settings.

This criterion-based clinical audit will review labour records of women admitted with the intention of vaginal birth and will include an anonymous staff survey to identify barriers to the use of assisted vaginal delivery.

02

Conditions studied

  • Labor (Obstetrics)--Complications

Keywords

  • Labour progress
  • Assisted vaginal birth
  • Vacuum extraction
  • Clinical audit
  • Assiut
03

In context

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women of any age and parity admitted in labour with the intention of vaginal birth at Women's Health Hospital, Assiut University.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women admitted in labour with the intention of vaginal birth
  • Singleton live pregnancy with cephalic presentation
  • Gestational age of 37 completed weeks or more
  • Spontaneous or induced labour

Exclusion criteria

Exclusion Criteria:

  • - Elective caesarean section or caesarean decided before onset of labour
  • Non-cephalic presentation or multiple pregnancy
  • Intrauterine fetal death or major congenital anomaly
  • Absolute to vaginal birth
  • Delivery before arrival or transfer to another facility
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Women in Labour

    Women admitted in labour with the intention of vaginal birth whose records will be audited against predefined standards.

06

What researchers measure

Primary outcomes

  1. Number of women eligible for assisted vaginal birth

    Number of women who fulfil the predefined criteria for assisted vaginal birth during the second stage of labour.

    Time frame: Baseline

Secondary outcomes

  1. Number of women who receive assisted vaginal birth

    Number of eligible women in whom assisted vaginal birth is performed.

    Time frame: Baseline

  2. Number of women delivered by caesarean section at full dilatation

    Number of eligible women delivered by caesarean section at full cervical dilatation without an attempt at assisted vaginal birth.

    Time frame: Baseline

  3. Compliance with labour progress documentation standards

    Number of cases in which labour progress is recorded according to the agreed audit standards.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07926061
Lead sponsor
Assiut University
Responsible party
Reham Abdelhameed Ali (Resident Physician, Department of Obstetrics and Gynecology, Assiut University) — Principal investigator
First posted
Nov 9, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
Nov 10, 2027 (estimated)
Completion
Feb 20, 2028 (estimated)
Last update
Nov 9, 2026

Study contacts

Reham A Ali, Resident
Contact
alireham120@gmail.com
+20 10 29464120
Omar M Mohamed, prof
study chair · Obstetrics and gynecology Department, Assiut University Hospitals

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion